These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3757078)

  • 41. [Biological and pharmacological effects of bioflavonoids].
    Eckert I; Kästner D
    Z Arztl Fortbild (Jena); 1969 Apr; 63(8):459-64. PubMed ID: 5306802
    [No Abstract]   [Full Text] [Related]  

  • 42. [The biological effects of flavonoids].
    Spilková J; Hubík J
    Cesk Farm; 1986 Jul; 35(6):278-86. PubMed ID: 3757078
    [No Abstract]   [Full Text] [Related]  

  • 43. [Flavonoids in medicine].
    Pałgan K; Drewa G
    Postepy Hig Med Dosw; 1994; 48(5):589-601. PubMed ID: 7638102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential and practical applications of acylated flavonoids.
    Viskupicová J; Ondrejovic M; Sturdík E
    Pharmazie; 2009 Jun; 64(6):355-60. PubMed ID: 19618669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
    Benavente-García O; Castillo J
    J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Flavonoids--characteristics and significance for therapy].
    Malińska D; Kiersztan A
    Postepy Biochem; 2004; 50(2):182-96. PubMed ID: 15597952
    [No Abstract]   [Full Text] [Related]  

  • 47. [Flavonoids and the cardiovascular system: can they be a therapeutic alternative?].
    Tenorio López FA; del Valle Mondragón L; Pastelín Hernández G
    Arch Cardiol Mex; 2006; 76 Suppl 4():S33-45. PubMed ID: 17469333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioactivity of flavonoids.
    Robak J; Gryglewski RJ
    Pol J Pharmacol; 1996; 48(6):555-64. PubMed ID: 9112694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological properties of flavonoids pertaining to inflammation.
    Manthey JA
    Microcirculation; 2000; 7(6 Pt 2):S29-34. PubMed ID: 11151968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds.
    Hendrich AB
    Acta Pharmacol Sin; 2006 Jan; 27(1):27-40. PubMed ID: 16364208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials.
    Bast A; Haenen GR; Bruynzeel AM; Van der Vijgh WJ
    Cardiovasc Toxicol; 2007; 7(2):154-9. PubMed ID: 17652822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.